Cadrenal Therapeutics CVKD Cash Flow Statement (2022-2026)

NASDAQ CVKD
$1.60 +0.00 (+0.00%)
As of: Aug 21, 2026 · 12:40 PM EDT
Cash Flow Statement Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025 Dec2025 Mar2026 Jun2026
Operating Activities
Net Income (Quarter) -0.17M-0.49M-0.99M-1.09M-5.01M-2.00M-1.78M-1.14M-1.66M-2.40M-2.73M-3.86M-3.33M
Depreciation and Depletion (Quarter) 506.00760.00190.00597.00597.00597.00597.00470.00407.00407.000.01M401.00401.00555.00555.00504.00
Share-based Compensation (Quarter) 0.45M0.29M0.17M0.10M0.10M0.16M0.19M0.20M0.87M0.55M0.49M2.80M0.46M2.10M1.40M
Gains from Investment Securities (Quarter) 0.00M0.01M0.02M3.88M0.22M
Cash from Operations (Quarter) -0.04M-0.45M-0.42M-0.29M-1.41M-0.80M-0.63M-0.69M-1.84M-1.53M-2.20M-1.79M-4.65M-3.03M-2.36M-2.57M-3.00M-2.23M
Depreciation, Depletion & Amortization
Amortizatization of Intangibles (Quarter) 0.00M0.01M0.02M0.04M0.01M
Amortization of Deferred Charges (Quarter) 89.0090.0089.00
Depreciation & Amortization (CF) (Quarter) 506.00760.00190.00597.00597.00597.00597.00470.00407.00407.000.01M401.00401.00555.00555.00504.00
Change in Working Capital
Change in Account Payables (Quarter) 0.02M0.19M0.10M0.10M-0.29M-0.04M0.06M0.03M0.23M0.36M-0.26M1.01M-0.22M-0.38M-0.28M0.04M0.17M0.05M
Change in Accured Expenses (Quarter) 0.12M0.02M0.23M0.50M-0.60M0.01M0.12M0.24M-0.20M0.26M0.07M0.41M-0.62M0.22M-0.05M0.20M-0.70M0.33M
Other Working Capital Changes (Quarter) 0.00M0.00M0.00M-0.00M1.00-1.001.00-1.00
Investing Activities
Capital Expenditures (Quarter) 1.001.000.00M0.00M
Cash from Investing Activities (Quarter) -1.00-1.00-0.00M-0.00M
Financing Activities
Other financing activities (Quarter) 0.01M450.000.25M5.16M-5.16M298.002.06M-2.02M0.02M1.37M1.20M
Cash from Financing Activities (Quarter) 0.51M0.05M0.46M0.22M5.41M6.51M-0.01M298.001.53M7.45M1.97M1.26M0.65M2.72M1.30M2.31M
Change in Capital Stock
Net Equity Issued and Repurchased (Quarter) 5.41M3.51M-0.09M0.67M0.85M-0.06M0.09M
Additional items
Change in Cash (Quarter) 0.46M-0.40M0.04M-0.07M4.00M-0.80M5.88M-0.71M-1.84M-1.53M-0.67M5.65M-2.68M-1.77M-1.71M0.15M-1.70M0.08M
Free Cash Flow (Quarter) -0.04M-0.45M-0.42M-0.29M-1.41M-0.80M-0.63M-0.69M-1.84M-1.53M-2.20M-1.79M-4.65M-3.03M-2.36M-2.57M-3.00M-2.23M
Net Cash Flow (Quarter) 0.46M-0.40M0.05M-0.07M4.00M-0.80M5.88M-0.71M-1.84M-1.53M-0.67M5.66M-2.68M-1.77M-1.71M0.15M-1.70M0.08M